This presentation provides the laboratory and operational requirements of immuno-oncology trials, and explores trends in I-O drug development and biomarker usage. IQVIA Laboratories presented at the Immuno-Oncology 360° 2019 conference as part of a plenary session.
IQVIA Laboratories has a unique role in immuno-oncology drug development, providing clinical laboratory services and utilizing early engagement and continuous communication with partners and clients to drive higher quality results.
Download this presentation to learn more.
Speaker:
Patrice Hugo, PhD, Chief Scientific Officer
Related Insights
Managing Informed Consent Samples from Clinical Trials
A set of best practices for the definition, tracking and management of allowable use attributes associated with samples collected in protocol based clinical trials
Labmatrix®
Tracking clinical trial samples and consents to support total sample lifecycle management
Consent Tracking for Clinical Trial Samples
Optimizing the management of consents throughout the entire lifecycle
Tracking Clinical Trial Samples
Optimizing the management of samples throughout the entire lifecycle
Blockchain in Clinical Research Sample Management
Distributed Ledger Technology (DLT) in clinical trials
Managing Sample Data from Vendors
Best Practices for Clinical Trials
Using Labmatrix® at a Big Biopharma Company to Reduce Clinical Trial Delays, Costs and Regulatory Risks
Managing Sample Data from Vendors
Best practices for clinical trials
eConsent and BioBanking
How to reduce costs while improving efficiencies
